Uniphar (LON:UPR) Stock Price Down 0.5% - Should You Sell?

Shares of Uniphar plc (LON:UPR - Get Free Report) were down 0.5% on Tuesday . The stock traded as low as GBX 196 ($2.48) and last traded at GBX 199.05 ($2.51). Approximately 6,653 shares were traded during trading, a decline of 80% from the average daily volume of 32,461 shares. The stock had previously closed at GBX 200 ($2.53).

Analyst Upgrades and Downgrades

Separately, Shore Capital reaffirmed a "buy" rating on shares of Uniphar in a research report on Tuesday, January 28th.

Uniphar Stock Performance

The company has a market cap of £619.45 million, a price-to-earnings ratio of 13.84 and a beta of 0.75. The firm has a 50-day simple moving average of GBX 182.61 and a 200 day simple moving average of GBX 197.78. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.